Wells Fargo’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$375K Buy
80,366
+10,485
+15% +$49K ﹤0.01% 3990
2025
Q1
$384K Sell
69,881
-9,155
-12% -$50.3K ﹤0.01% 3842
2024
Q4
$268K Buy
79,036
+22,050
+39% +$74.7K ﹤0.01% 4128
2024
Q3
$162K Sell
56,986
-2,667
-4% -$7.6K ﹤0.01% 4330
2024
Q2
$134K Buy
59,653
+7,409
+14% +$16.7K ﹤0.01% 4412
2024
Q1
$115K Buy
52,244
+7,402
+17% +$16.4K ﹤0.01% 4440
2023
Q4
$105K Buy
44,842
+7,853
+21% +$18.5K ﹤0.01% 4462
2023
Q3
$68.8K Sell
36,989
-28,900
-44% -$53.8K ﹤0.01% 4660
2023
Q2
$173K Buy
65,889
+29,952
+83% +$78.5K ﹤0.01% 4429
2023
Q1
$58.6K Buy
35,937
+24,824
+223% +$40.5K ﹤0.01% 4798
2022
Q4
$14.8K Sell
11,113
-2,445
-18% -$3.25K ﹤0.01% 5071
2022
Q3
$21K Sell
13,558
-1,189
-8% -$1.84K ﹤0.01% 5051
2022
Q2
$23K Buy
14,747
+3,634
+33% +$5.67K ﹤0.01% 5102
2022
Q1
$28K Sell
11,113
-566
-5% -$1.43K ﹤0.01% 5554
2021
Q4
$34K Buy
11,679
+9,113
+355% +$26.5K ﹤0.01% 5668
2021
Q3
$6K Buy
2,566
+1,000
+64% +$2.34K ﹤0.01% 6011
2021
Q2
$6K Sell
1,566
-8,398
-84% -$32.2K ﹤0.01% 5963
2021
Q1
$45K Sell
9,964
-33,827
-77% -$153K ﹤0.01% 5508
2020
Q4
$215K Buy
43,791
+18,204
+71% +$89.4K ﹤0.01% 4917
2020
Q3
$151K Sell
25,587
-9,154
-26% -$54K ﹤0.01% 4919
2020
Q2
$93K Buy
34,741
+9,816
+39% +$26.3K ﹤0.01% 5041
2020
Q1
$49K Sell
24,925
-44,031
-64% -$86.6K ﹤0.01% 5125
2019
Q4
$486K Buy
68,956
+18,065
+35% +$127K ﹤0.01% 4296
2019
Q3
$501K Buy
50,891
+8,918
+21% +$87.8K ﹤0.01% 4274
2019
Q2
$480K Buy
41,973
+29,682
+241% +$339K ﹤0.01% 4295
2019
Q1
$123K Buy
12,291
+8,994
+273% +$90K ﹤0.01% 4980
2018
Q4
$56K Buy
3,297
+2,362
+253% +$40.1K ﹤0.01% 5204
2018
Q3
$16K Buy
+935
New +$16K ﹤0.01% 5523